Chemical Structure : Nintedanib
CAS No.: 656247-17-5
Catalog No.: PC-45898Not For Human Use, Lab Use Only.
Nintedanib (BIBF-1120) is a potent triple angiokinase (VEGFR/PDGFR/FGFR) inhibitor with IC50 of 5/38/18/104/5 nM for VEGFR-2/FGFR-1/PDGFRα/VEGFR-1/VEGFR-3, respectively.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 10 mg | $58 | In stock | |
| 25 mg | $98 | In stock | |
| 50 mg | $148 | In stock | |
| 100 mg | $228 | In stock | |
| 1 g | Get quote |
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Nintedanib (BIBF-1120) is a potent triple angiokinase (VEGFR/PDGFR/FGFR) inhibitor with IC50 of 5/38/18/104/5 nM for VEGFR-2/FGFR-1/PDGFRα/VEGFR-1/VEGFR-3, respectively.
Nintedanib (BIBF-1120) inhibits MAPK and Akt signaling pathways, show inhibition of cell proliferation (EC50=10-80 nM).
Nintedanib (BIBF-1120) is fully efficacious in xenograft models and orally active.
| M.Wt | 539.6248 | |
| Formula | C31H33N5O4 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
(Z)-methyl 3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
1. Roth GJ, et al. J Med Chem. 2009 Jul 23;52(14):4466-80.
2. Hilberg F, et al. Cancer Res. 2008 Jun 15;68(12):4774-82.
3. Kudo K, et al. Clin Cancer Res. 2011 Mar 15;17(6):1373-81.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright